FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/02/031069 [Registered on: 08/02/2021] Trial Registered Prospectively
Last Modified On: 05/02/2021
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Homeopathy 
Study Design  Other 
Public Title of Study   Study on the effects of homeopathic drug Folliculinum on E coli bacteria of urinary tract infected patients in laboratory and clinical verification of same. 
Scientific Title of Study   In vitro study of homeopathic drug-Folliculinum in different potencies on cultured Escherichia coli and its clinical verification in patients with urinary tract infection.  
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  AFIYA ALLOOR 
Designation  MD SCHOLAR 
Affiliation  GOVT HOMEOPATHIC MEDICAL COLLEGE KOZHIKODE 
Address  MD SCHOLAR DEPT OF CASE TAKING AND REPERTORISATION GOVT HOMEOPATHIC MEDICAL COLLEGE KOZHIKIDE KARAPARAMBA
MD SCHOLAR DEPT OF CASE TAKING AND REPERTORISATION GOVT HOMEOPATHIC MEDICAL COLLEGE KOZHIKIDE KARAPARAMBA
Malappuram
KERALA
673010
India 
Phone  9037867767  
Fax    
Email  afiyalloor@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  DRMANSOOR ALI K R 
Designation  PROFESSOR 
Affiliation  GOVT HOMEOPATHIC MEDICAL COLLEGE KOZHIKODE 
Address  PROFESSOR ROOM NO 5 2ND FLOOR DEPARTMENT OF CASE TKING AND REPERTORISATION GOVT HOMEOPATHIC MEICAL COLLEGE C KOXHIKODE KARAPARAMBA
PROFESSOR ROOM NO 5 2ND FLOOR DEPARTMENT OF CASE TKING AND REPERTORISATION GOVT HOMEOPATHIC MEICAL COLLEGE C KOXHIKODE KARAPARAMBA
Kozhikode
KERALA
673010
India 
Phone  9249337799  
Fax    
Email  similima@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  AFIYA ALLOOR 
Designation  MD SCHOLAR 
Affiliation  GOVT HOMEOPATHIC MEDICAL COLLEGE KOZHIKODE 
Address  PROFESSOR ROOM NO 5 2ND FLOOR DEPARTMENT OF CASE TKING AND REPERTORISATION GOVT HOMEOPATHIC MEICAL COLLEGE C KOXHIKODE KARAPARAMBA
PROFESSOR ROOM NO 5 2ND FLOOR DEPARTMENT OF CASE TKING AND REPERTORISATION GOVT HOMEOPATHIC MEICAL COLLEGE C KOXHIKODE KARAPARAMBA
Malappuram
KERALA
673010
India 
Phone  9037867767  
Fax    
Email  afiyalloor@gmail.com  
 
Source of Monetary or Material Support  
GOVT HOMEOPATHIC MEDICAL COLLEGE KOZHIKODE 
 
Primary Sponsor  
Name  AFIYA ALLOOR 
Address  MD SCHOLAR DEPT OF CASE TAKING AND REPERTORISATION GOVT HOMEOPATHIC MEDICAL COLLEGE KOZHIKODE 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
AFIYA ALLOOR  GOVT HOMEOPATHIC MEDICAL COLLEGE KOZHIKODE  GOVT HOMEOPATHIC MEDICAL COLLEGE . ROOM NO 7 2ND FLOORKOZHIKODE KARAPARAMBA PIN 673010
Kozhikode
KERALA 
9037867767

afiyalloor@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
INSTITUTIONAL ETHICS COMMITTEE  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N300||Acute cystitis,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  FOLLICULINUM 12C,30,200,1M 1M POTENCY  SMEDICINE GIVEN IN SINGLE DOSE POTENCY ORALLY AT AN INTERVEL OF 2 WEEK ACCORDING TO PATIENTS NEED. 
Comparator Agent  INDIDUALISED HOMEOPATHIC MEDICINE 12C,30,200,1M,1OM   MEDICINE GIVEN IN SINGLE DOSE ORALLY AT NEEDED POTENCY AFTER DETAILED CASE TAING BY PERFORMA. 
 
Inclusion Criteria  
Age From  20.00 Year(s)
Age To  50.00 Year(s)
Gender  Female 
Details  positive findings in urine microscopy and culture
Children aged below 10 and Female aged between 20 - 50 years.
patients willing to give written consent to participate in the trial.
 
 
ExclusionCriteria 
Details  1. Infected material of patients suffering a sexually transmitted disease like HIV, syphilis, gonorrhea, Kaposi sarcoma etc.
Cases with a severe systemic illness like meningitis and septicemia.
Patients having malignancy from any origin.
 
 
Method of Generating Random Sequence   Random Number Table 
Method of Concealment   Alternation 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Reducing the bacterial colony count in urine culture   2 MONTHS INTERVEL 
 
Secondary Outcome  
Outcome  TimePoints 
Inhibition of bacterial growth  2 WEEKS 
 
Target Sample Size   Total Sample Size="70"
Sample Size from India="70" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   15/02/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="0"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   NIL 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

AIM-To explore the antimicrobial effect of Homoeopathic drugs Folliculinum in various potencies against the Escherichia coli and clinical verification in patience with  urinary tract infection.

 Objective

·         To determine the in vitro effectiveness of Homoeopathic drug Folliculium in various potencies against inhibiting the human pathogen E .coli.

·         To find out the individual effectiveness of specific homeopathic folliculinum and Homoeopathic constitutional medicines in changing the bacterial count in patients  with urinary tract infection.

·         To compare the effectiveness of homoeopathic specific medicine Folliculinum relative to constitutional medicines in changing the bacterial count in patients with urinary tract infection.


 
Close